<DOC>
	<DOCNO>NCT00540501</DOCNO>
	<brief_summary>This study 4 period study see interaction Orally-Administered Oseltamivir Intravenous Zanamivir Healthy Thai Adult Subjects</brief_summary>
	<brief_title>A Study Evaluate Orally-Administered Oseltamivir Intravenous Zanamivir Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Zanamivir</mesh_term>
	<criteria>Inclusion criterion : Healthy Volunteer ( ) confirm physical exam , clinical lab , ECGs , vitals Must woman nonchildbearing potential willing abstain intercourse two week prior study drug administration throughout study willing use two acceptable method birth control . Exclusion criterion : Subjects history certain heart problem subject Hepatitis B , C HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>zanamivir ,</keyword>
	<keyword>influenza virus ,</keyword>
	<keyword>healthy volunteer ,</keyword>
	<keyword>PK , drug interaction ,</keyword>
	<keyword>IV , oseltamivir .</keyword>
</DOC>